EGYSORB (Braided Polyglycolic Acid (PGA) )

Product Description

INDICATIONS:

EGYSORB sutures are intended for use in general soft tissues approximation &/or ligation including ophthalmic surgery.

Application:

Depending on patient condition and surgeon experience, needle and suture size can be selected

PERFORMANCE :

EGYSORB sutures elicits a minimal tissue reaction and in growth of fibrous connective tissue.

Absorption occurs by means of hydrolysis, where the polymer degrades to glycolic acid which is subsequently absorbed and metabolized in the body. Absorption begins as a loss of tensile strength and end by a total loss of mass

              Note: Complete absorption will be essentially done after *0to*0 days, Above percents are averages with respect of USP size difference. 

CONTRAINDICATIONS:

As all absorbable suturesEGYSORBis contraindicated where extended approximation of tissue under stress is required.

WARNINGS & PRECAUTIONS:

Under certain circumstances, notable procedures, immobilization of joints by external support may be employed at the discretion of surgeon.

The safety and effectiveness of EGYSORB sutures in cardiovascular and neurological tissues have not been established.

Each USP size has its upper limits tensile strength (USP and EP), over stretch above this limits may lead to suture damage.

Acceptable surgical practice should be followed with respect to drainage and closure of infected wounds.

EGYSORB sutures require the standard surgical technique of flat and square ties with additional throws if indicated by surgical circumstances and the experiences of the surgeon. Skin sutures which remain in place longer than 7 days may cause localized irritation and should be snipped off or removed (as all absorbable sutures).Consideration should be taken in the use of absorbable sutures in tissues with poor blood supply as sutures extrusion and delayed absorption may occur. Subcuticular sutures should be